Release Date: June 30, 2025
Expiration Date: June 30, 2026
Activity Overview
This online, on-demand virtual symposium brings together renowned experts in neurotrophic keratitis (NK). In this educational program, these experts discuss the symptoms associated with NK, present video demonstrations of various techniques for corneal sensitivity testing, and share their perspectives and best practices for diagnosing and treating patients with NK.
This educational activity is an archive of the virtual symposium held on May 30, 2025.
Target Audience
This online educational activity is directed toward optometrists, ophthalmologists, and other eyecare professionals involved in the management of patients with neurotrophic keratitis.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Summarize the importance of a timely and accurate diagnosis of neurotrophic keratitis
- Integrate corneal sensitivity testing into the assessment of ocular surface disease
John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA
Director, Specialty Contact Lens Division
Cornea and Laser Eye Institute
CLEI Center for Keratoconus
Assistant Clinical Professor, Department of Ophthalmology
Rutgers New Jersey Medical School
Adjunct Clinical Professor, New England College of Optometry
State University of New York College of Optometry
Illinois College of Optometry
Teaneck, NJ
Disclosures: Research/Consultant: CorneaGen, OSI, Ovitz, UltraVision; Consultant: Corza medical, Essiri; Speaker: Glaukos, Oculus.
John Hovanesian, MD, FACS
President, Harvard Eye Associates
Specialist in Cornea, External Ocular Disease, Refractive and Cataract Surgery
Clinical Faculty, UCLA Jules Stein Eye Institute
Laguna Hills, CA
Disclosures: Grant/Research Support: AcuFocus, Aerie, Alcon, Allergan, Bausch + Lomb, Cord LLC, EyePoint, Glaukos, Imprimis, Johnson & Johnson Vision, Novartis, Omeros, On Point Vision, Research Insight LLC, Sight Sciences, Sun Pharma, Zeiss; Consultant: AcuFocus, Aerie, Alcon, Allergan, Apellis, Avellino Labs USA, Azura Ophthalmics, BlephEx, Bruder Healthcare, BVI, Centricity Vision, Cloudbreak Therapeutics, Cord LLC, CorneaGen, Dompe, Eyedetec, EyePoint, Glaukos, Glint Pharma, Gobiquity, GSK, Hasa Optix, Horizon Therapeutics, Hoya, Imprimis, Johnson & Johnson Vision, Kala, Novartis, Ocular Therapeutix, Oculis, Omeros, On Point Vision, Orasis, Oyster Point Pharma, Rayner, Research Insight LLC, Sensimed, SightLife, Sun Pharma, Tarsus, TearLab, Thea Pharma, Touch Ophthalmology, Trefoil Therapeutics, Vindico Medical Education, Visus, Zeiss; Other: Alcon, Alicia Surgery Center, Allegro Ophthalmics, Allergan, Apellis, Bausch + Lomb, BlephEx, Bruder Healthcare, BVI, Cloudbreak Therapeutics, Cord LLC, CorneaGen, Crisper, Dompe, Eyedetec, EyePoint, Glaukos, Glint Pharma, Gobiquity, Guardion Health Sciences, Harvard Eye Associates, Hasa Optix, Horizon Therapeutics, Hoya, Johnson & Johnson Vision, Novartis, Ocular Therapeutix, Omeros, Orasis, Research InSight LLC, RxSight, Sight Sciences, SightLife, Slack Books, Sun Pharma, Tarsus, Tear Clear, Trefoil Therapeutics, Versant Ventures and its investments, Visionary Ventures Fund 1 and 2 and its investments, Visus, Zeiss.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here

